KLK3 and prostate cancer: Nevertheless, research by Elgamal et al. demonstrated the detectability of PSA in both normal and cancerous tissues remote from the prostate, indicating that exclusive reliance on PSA for diagnosis may lead to an overestimation of prostate cancer prevalence 86.